Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol followed by vitamins C and E in chronic Chagas disease with cardiac involvement
RBR-95jnqpPhase 4Completed
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carvedilol, vitamin e and ascorbic acid in American trypanosomiasis (CD) and Chagas cardiomyopathy (CCC) (2 arms), sponsored by Federal University of Rio de Janeiro. Started Jan 2010; status: completed.
02
Drugs
carvedilolvitamin eascorbic acid
03
Conditions
American trypanosomiasis (CD)Chagas cardiomyopathy (CCC)
Beyond the preview
Go deeper on RBR-95jnqp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-95jnqp.